160 related articles for article (PubMed ID: 7129032)
1. Oral pulse prednisone therapy in the treatment of HBsAg negative chronic active hepatitis.
Chase WF; Winn RE; Mayes GR
Gastroenterology; 1982 Dec; 83(6):1292-6. PubMed ID: 7129032
[TBL] [Abstract][Full Text] [Related]
2. Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis.
Davis GL; Czaja AJ; Ludwig J
Gastroenterology; 1984 Dec; 87(6):1222-7. PubMed ID: 6489694
[TBL] [Abstract][Full Text] [Related]
3. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
Maier KP; Lepiorz H; Berthold H; Gerok W
Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic active hepatitis (CAH): a retrospective review of 130 patients.
Giusti G; Ruggiero G; Galanti B; Piccinino F; Russo M; Galante D; Sagnelli E; Utili R; Pasquale G; Nardiello S; Aloisio V
Hepatogastroenterology; 1981 Oct; 28(5):245-9. PubMed ID: 7047337
[TBL] [Abstract][Full Text] [Related]
5. Methyl-prednisolone treatment of serum HBsAg negative chronic active hepatitis occurring in transfusion-dependent thalassemia major.
De Virgiliis S; Argiolu F; Rais M; Cossu P; Toccafondi C; Sanna G; Cornacchia G; Nucaro A; Bertolino F; Ferreli A
Helv Paediatr Acta; 1983 Aug; 38(3):255-65. PubMed ID: 6618892
[TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
Tanno H; Fay O; Roldán L; Vorovioff J
Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
[TBL] [Abstract][Full Text] [Related]
7. [The immune compartment in chronic active liver disease responsive and non-responsive to corticoid therapy].
Buligescu L; Mateescu-Cutcudache O; Mihai E
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(1):91-5. PubMed ID: 2884716
[No Abstract] [Full Text] [Related]
8. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive therapy in chronic active hepatitis (CAH). A multicentric retrospective study on 867 patients. A report from a study group for CAH of the Italian Association for the study of the liver.
Giusti G; Piccinino F; Galanti B; Sagnelli E; Ruggiero G; Gallo C
Hepatogastroenterology; 1984 Feb; 31(1):24-9. PubMed ID: 6698485
[TBL] [Abstract][Full Text] [Related]
10. [T-lymphocyte subpopulations in chronic active hepatitis].
Fucíková T; Brodanová M; Bartůnková J; Skopový P; Hausner P; Krupicka J
Sb Lek; 1991 Mar; 93(1-2):27-32. PubMed ID: 2047739
[TBL] [Abstract][Full Text] [Related]
11. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
[TBL] [Abstract][Full Text] [Related]
12. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of thymostimulin treatment in hepatitis B surface antigen-positive chronic active liver disease. Results of a randomized clinical trial.
Romeo F; Arcoria D; Palmisano L; Polosa P
Arzneimittelforschung; 1985; 35(8):1317-22. PubMed ID: 3907642
[TBL] [Abstract][Full Text] [Related]
14. Therapy of HBsAg-negative chronic active hepatitis in transfusion-dependent thalassemia major.
De Virgiliis S; Argiolu F; Rais M; Cossu P; Toccafondi C; Sanna G; Cornacchia G; Nucaro A; Ferreli A; Cao A
Birth Defects Orig Artic Ser; 1982; 18(7):355-60. PubMed ID: 6819018
[No Abstract] [Full Text] [Related]
15. Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.
Safadi R; Israeli E; Papo O; Shibolet O; Melhem A; Bloch A; Rowe M; Alper R; Klein A; Hemed N; Segol O; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Am J Gastroenterol; 2003 Nov; 98(11):2505-15. PubMed ID: 14638356
[TBL] [Abstract][Full Text] [Related]
16. Influencing immune perturbations by prolonged corticotherapy in the chronic active liver disease.
Banciu T; Arcan P; Stroe A
Med Interne; 1985; 23(3):177-83. PubMed ID: 4048798
[TBL] [Abstract][Full Text] [Related]
17. Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis.
Nair PV; Tong MJ; Stevenson D; Roskamp D; Boone C
Liver; 1985 Feb; 5(1):8-12. PubMed ID: 3884951
[TBL] [Abstract][Full Text] [Related]
18. Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients.
Thiele DL; DuCharme L; Cunningham MR; Mimms LT; Cuthbert JA; Lee WM; Combes B
Am J Gastroenterol; 1996 Feb; 91(2):300-8. PubMed ID: 8607497
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of long-term weekly interferon-beta administration for chronic hepatitis B.
Kagawa T; Morizane T; Saito H; Tsunematsu S; Tada S; Kumagai N; Tsuchimoto K; Sugiura H; Mukai M; Tsuchiya M
Am J Gastroenterol; 1993 Feb; 88(2):212-6. PubMed ID: 8424423
[TBL] [Abstract][Full Text] [Related]
20. [Course of chronic virus hepatitis B in children and attempts at modifying its treatment].
Kowalik-Mikołajewska B
Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):258-60. PubMed ID: 7694262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
